Bruker Corporation (NASDAQ:BRKR) currently has a daily average trading volume of 752.00K but it saw 314837 shares traded on Wednesday. With a market cap of 10.07B USD, stock’s current market price of $68.44 came rising about 0.19 while comparing to the previous closing price of $68.31. In past 52 weeks, the stock remained buoying in the range of price level as high as $87.22 and as low as $48.42. In the recent trading on the day, stock has struck highest price mark of $69.08 while lowest mark touched by it was $67.98.
Taking a look at 20-day trading activity of Bruker Corporation (BRKR) gives us an average price of $65.98, while its current price level is -21.53% below from 52-week high level whereas it is 41.35% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $59.17 while that of 200 days or SMA-200 reads an average of $61.95. A closer look into the stock’s movement over the week reveals that its volatility is standing at 2.94% during that period while stretching the period over a month that increases to 3.69%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 64.66 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the UBS which initiated the stock as “Buy” in its note to investors issued on October 21, 2022, recommending a price target of $70 for it. Citigroup upgraded its recommendation for the stock as a “Buy” from “Neutral” on August 22, 2022 while assigning a price target range of $70-$80. Cowen issued its recommendations for the stock as it resumed the price target for the stock is $68.
Over the week, BRKR’s stock price is moving 0.16% up while it is 12.58% when we observe its performance for the past one month. Year-to-date it is -18.44% down and over the past year, the stock is showing a downside performance of -11.88%.
The latest quarterly earnings report issued by the company was for quarter ended 6/29/2022, when its quarterly earnings per share (EPS) of $0.45 beat the consensus estimate of $0.45 for the same. The company is expected to be releasing its next quarterly report in 02/13/2023, for which analysts forecasted an EPS of $0.55 while estimate for next year EPS is $2.29. For BRKR, analysts are forecasting an EPS-growth rate of 9.00% for current year and estimate for EPS growth in next year is 10.90%. In next quarter, company is expected to be making quarterly sales of $702.61 million as analysts are expecting the sales for current fiscal year at $2.5 billion and seeing the company making $2.62 billion in sales next year. Moreover, analysts are in estimates of $608.2 million for current-quarter revenue.
Currently, Bruker Corporation’s total number of outstanding shares is 147.80M with 32.55% of that held by the insiders while 71.23% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 12.50% and return on equity (ROE) at 27.50%. It has a price to earnings ratio (P/E ratio) of 37.48 while having a 26.96 of forward P/E ratio. Stock’s beta reads 1.21. Stock has a price to book (P/B) ratio of 10.79 while price to sale or P/S ratio amounts to 4.02. Its return on asset (ROA) is 7.90% on average.
A filing at the U.S. Securities and Exchange Commission revealed that T Rowe Price Mid Cap Growth Fund came shrinking its share ownership by -1.90% in the Bruker Corporation (BRKR) decreasing its stake to 4.64% with control over -0.13 million shares in the company. As per SEC documents, T Rowe Price Mid Cap Growth Fund sought 6,867,300 of company’s common stock of worth $424.67 million as per recent closing price of the stock. T Rowe Price Mid Cap Growth Fund is not the only institutional holder which restructured its stake in Bruker Corporation, as Vanguard Total Stock Market Index picked 3,113,504 shares of worth $192.54 million to bring its holdings to a total of 22142.0 shares. In the most recent quarter, iShares Core S&P Mid Cap ETF came rising its stake by 0.04% in the company and now holds 3.03 million or 2.04% of the company’s stake having worth of about 187.2 million.